middle.news
Mayne Pharma Wins Longer IMVEXXY Runway With 2032 Generic Deal
9:49am on Wednesday 30th of September, 2026 AEST
•
Pharmaceuticals
Read Story
Mayne Pharma Wins Longer IMVEXXY Runway With 2032 Generic Deal
9:49am on Wednesday 30th of September, 2026 AEST
Key Points
Sun Pharma generic entry agreed for 21 October 2032
Settlement subject to court approval and earlier-entry provisions
No financial payment or upfront consideration between the parties
IMVEXXY sales rose 8% to US$29.3 million
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Mayne Pharma (ASX:MYX)
OPEN ARTICLE